Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Colorectal Acf Screening. Regression. and P-261005125
University of Texas MD Anderson Cancer Center
Search grants from University of Texas MD Anderson Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The influence of 3D printed prostheses on neural activation patterns of the primary motor cortex in children with unilateral congenital upper-limb reductions
Neurotrophins and Cocaine-Induced Neuronal Plasticity
Cytokine Signaling Pathways Regulating a G1 Checkpoint
Gcrc-Cap
New Detector Screen Media for Autoradiography
Recently added grants:
Quantifying renal injury among the most commonly used clinical antibiotic combinations
Host-derived extracellular vesicles in inflammatory caspase activation
Mechanisms underlying poor skin host defense in diabetic conditions
Mechanisms in Polyomavirus Assembly
Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005125-001
Application #
6994810
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2004
N01 CN
Phase II Clinical Trial of Colorectal Acf Screening. Regression. and P-261005125
/ University of Texas MD Anderson Cancer Center
NIH 2000
N01 CN
Phase II Clinical Trial of Colorectal Acf Screening, Reg
Sinicrope, Frank / University of Texas MD Anderson Cancer Center
$1,136,114
Comments
Be the first to comment on this grant